Generali Investments Towarzystwo Funduszy Inwestycyjnych (TFI)’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$126K Hold
1,000
0.05% 139
2026
Q1
$139K Hold
1,000
0.07% 127
2025
Q4
$123K Hold
1,000
0.06% 128
2025
Q3
$111K Sell
1,000
-300
-23% -$34.1K 0.06% 129
2025
Q2
$144K Hold
1,300
0.08% 119
2025
Q1
$146K Hold
1,300
0.09% 114
2024
Q4
$120K Sell
1,300
-1,100
-46% -$99K 0.07% 122
2024
Q3
$201K Hold
2,400
0.13% 95
2024
Q2
$165K Buy
2,400
+200
+9% +$13.3K 0.11% 97
2024
Q1
$161K Buy
2,200
+350
+19% +$26.9K 0.11% 98
2023
Q4
$150K Hold
1,850
0.12% 95
2023
Q3
$150K Buy
1,850
+150
+9% +$11.5K 0.12% 95
2023
Q2
$131K Buy
1,700
+340
+25% +$27.1K 0.11% 106
2023
Q1
$113K Buy
+1,360
New +$113K 0.12% 107

Other funds holding GILD

Generali Investments Towarzystwo Funduszy Inwestycyjnych (TFI)'s GILD Position: Q2 2026 in Review

Generali Investments Towarzystwo Funduszy Inwestycyjnych (TFI) held its Gilead Sciences (GILD) position steady in Q2 2026 at 1,000 shares worth $126K. The position accounts for 0.05% of the portfolio, ranked #139.

Generali Investments Towarzystwo Funduszy Inwestycyjnych (TFI) first reported a position in GILD in Q1 2023 and has held it in 14 quarters since. The position peaked at $201K in Q3 2024. 2,268 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • Generali Investments Towarzystwo Funduszy Inwestycyjnych (TFI) held 1,000 shares of Gilead Sciences worth $126K as of Q2 2026.
  • Generali Investments Towarzystwo Funduszy Inwestycyjnych (TFI) left its Gilead Sciences share count unchanged in Q2 2026.
  • Gilead Sciences made up 0.05% of Generali Investments Towarzystwo Funduszy Inwestycyjnych (TFI)'s portfolio in Q2 2026, its #139 holding.
  • Generali Investments Towarzystwo Funduszy Inwestycyjnych (TFI) first reported a position in Gilead Sciences in Q1 2023 and has held it in 14 quarters since.
  • Generali Investments Towarzystwo Funduszy Inwestycyjnych (TFI)'s Gilead Sciences position peaked at $201K in Q3 2024.
  • 2,268 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Generali Investments Towarzystwo Funduszy Inwestycyjnych (TFI)'s 13F filing for Q2 2026, filed 22 Jul 2026.